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Accepted 12 January 2021; Published online 18 January 2021AbstractBackground and Objective: This article explores the need for conceptual advances and practical guidance in the application of the
GRADE approach within public health contexts.
Methods: We convened an expert workshop and conducted a scoping review to identify challenges experienced by GRADE users in
public health contexts. We developed this concept article through thematic analysis and an iterative process of consultation and discussion
conducted with members electronically and at three GRADE Working Group meetings.
Results: Five priority issues can pose challenges for public health guideline developers and systematic reviewers when applying
GRADE: (1) incorporating the perspectives of diverse stakeholders; (2) selecting and prioritizing health and ‘‘nonhealth’’ outcomes; (3)
interpreting outcomes and identifying a threshold for decision-making; (4) assessing certainty of evidence from diverse sources, including
nonrandomized studies; and (5) addressing implications for decision makers, including concerns about conditional recommendations. We
illustrate these challenges with examples from public health guidelines and systematic reviews, identifying gaps where conceptual advances
may facilitate the consistent application or further development of the methodology and provide solutions.
Conclusion: The GRADE Public Health Group will respond to these challenges with solutions that are coherent with existing guidance
and can be consistently implemented across public health decision-making contexts.  2021 The Author(s). Published by Elsevier Inc.
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1. Introduction 1.2. Background1.1. Overview
For the past decade, the GRADE Working Group has
produced tools and guidance with the aim of reducing un-
necessary confusion and variation in rating the certainty
in synthesized evidence and improving the transparency
and methodological rigor of guidelines. Several GRADE
outputs and project groups have specifically addressed pub-
lic health topics and used examples from public health
guidelines [1e3]. At the same time, public health guideline
developers and others using GRADE in public health-
related contexts have identified ongoing challenges. To
address these challenges and consider the solutions, the
GRADE Working Group approved in 2017 the formation
of the GRADE Public Health Project Group. This article,
which is the first output of this project group, is not
GRADE guidance but a GRADE concept article. A
GRADE concept article is a new type of communication
from the GRADE Working Group that discusses the need
for conceptual advances in GRADE methodology.
This article reports the results of activities undertaken to
identify some of the challenges relating to GRADE and pub-
lic health guidelines, specifically through an initial stake-
holder workshop and a scoping review. We propose
priority areas for further consideration and explain the ratio-
nale for these choices. We present four case studies of public
health guidelines and systematic reviews (Boxes 1-4) to
illustrate how these challenges have been encountered in
practice. The article concludes by summarizing the types
of solutions that may be proposed for these challenges and
the next steps for the GRADE Public Health Group.Public health is concerned with ‘‘preventing disease,
prolonging life, and promoting health through the orga-
nized efforts of society.’’ [4]. Public health encompasses
three domainsdhealth protection, health services, and
health improvement [5]dwithin a disciplinary approach
which recognizes the impact of social determinants on indi-
vidual and population health outcomes and the importance
of reducing health inequalities. Decisions made by public
health practitioners, policymakers, and organizations may
relate to interventions that are not implemented at the indi-
vidual level, including health system reform, regulation of
unhealthy commodities (such as taxation of alcohol or
sugar-sweetened beverages), infrastructure development,
and social security policies. Depending on the approach
taken, policy goals may be competing or may produce con-
tradictory results, for example, when addressing health in-
equalities [6]. Decisions about such interventions and
situations involve stakeholders from many different profes-
sions and organizations. Consensus on critical outcomes
may be challenging to achieve and evidence from well-
conducted randomized studies may be lacking. However,
despite any lack of randomized studies, decisions must be
based on the best available evidence.
In this context, the GRADE approach has strengths which
are well recognized. GRADE’s structured and transparent
methods for integrating evidence into decisions have been
tested and implemented by guideline developers worldwide.
Previous research has reported the adoption and further
development of GRADE methods in public health contexts
[7e11]. Previous research has also investigated stakeholder
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Key findings
 Nine studies of guideline developers’ experiences
reported challenges when using GRADE in public
health and related fields.
 The GRADE Public Health project group will
respond to these challenges by producing guidance
relating to social determinants, population-level
outcomes, and rating certainty of evidence from in-
terrupted time series.
What this adds to what was known
 Thematic analysis indicates the challenges relate to
diverse perspectives and outcomes, decision-
making thresholds, and nonrandomized studies.
 Case studies drawing on Cochrane reviews and
public health guidelines provide examples of how
these challenges are encountered in practice.
What is the implication and what should change
now?
 Detailed examples, new guidance, and targeted
training materials should be developed to support
public health and public policy audiences using
GRADE.
views and experiences with GRADE and confirmed that
GRADE principles and processes are applicable to public
health systematic reviews and guidelines [12e14]. Howev-
er, challenges have also been identified for which various
solutions have been proposed [12,14e20]. These chal-
lenges, along with the existence of multiple proposed solu-
tions, represent areas in which further elaboration of
GRADE guidance and production of exemplars may be
beneficial to ensure consistent application of the methodol-
ogy, support the production of high-quality systematic re-
views and evidence-based guidelines, and allow for
further improvement of the GRADE system.
To explore experiences of GRADE users and lay the
foundations for a GRADE public health project group,
guideline developers and systematic reviewers were invited
to participate in a workshop on GRADE for public health at
the Global Evidence Summit in Cape Town, South Africa,
in September 2017. Twenty participants contributed to a
facilitated discussion of challenges encountered when
applying GRADE to public health topics. Participants re-
ported issues with agreeing on critical outcomes, assessing
certainty when the body of evidence includes findings from
disciplines other than health, making appropriate use of
nonrandomized studies, and addressing stakeholder con-
44 M. Hilton Boon et al. / Journal of Ccerns about weak or conditional recommendations. In addi-
tion, participants raised the issue of the broad range of
stakeholders involved in public health decision-making
and how to address the differences and competing interests
that may arise when guidelines apply to sectors other than
health. Further challenges in applying GRADE included the
need to integrate the perspectives of different disciplines
and professions in areas such as planning, housing, trans-
port, and social security; the need to address competing
policy priorities and resource considerations across govern-
mental agencies and geographical boundaries; and the
involvement of both public sector and commercial interests.
The formation of the GRADE Public Health project
group was subsequently approved by the GRADE Guid-
ance Group in October 2017 with the overarching goal to
advance GRADE methodology in the development of pub-
lic health guidelines. The work of the GRADE Public
Health Group builds on previously developed and in-
development GRADE guidance and related research on
topics including equity, complex interventions, modeling
studies, nonrandomized studies (NRS), and environmental
and occupational health [21e27]. Here, we particularly
focus on interventions that impact on whole populations
or large population groups (i.e., are not delivered at the in-
dividual level or whose benefits are realized at a population
level). Examples of such interventions include regulation of
unhealthy commodities (e.g., restrictions on transfats in
processed foods and minimum unit pricing of alcohol);
the provision of new infrastructure (e.g., clean water and
sanitation, affordable housing, and modifications to trans-
port); vaccination programs; and health system reforms
(e.g., the integration of health and social care services).2. Methods
We conducted a scoping review with the aim of investi-
gating (i) experiences of applying GRADE within public
health systematic reviews and guideline development and
(ii) existing research activity in this area. We included
peer-reviewed published research on experiences, barriers,
and facilitators encountered in public health contexts in
the adoption of GRADE. We did not include methodolog-
ical or technical documents that reported only the methods
and not the experiences or reflections of reviewers or devel-
opers. We searched Medline and Embase (date range
2000e2018; see online supplement for search strategies);
used the snowballing technique to identify additional rele-
vant studies; searched the reference lists of included arti-
cles; and contacted experts in the field. We performed a
narrative synthesis using thematic analysis to identify key
issues and challenges reported in the literature. We then
developed the analysis through an iterative process of
consultation and discussion conducted with GRADE Work-
ing Group members electronically and at three GRADE
Working Group meetings.
Case study 1 Cochrane systematic reviews on unconditional cash transfers
Contributed by: Stefan Lhachimi
Background
Unconditional cash transfers (UCTs, money provided without obligation) are an intervention that addresses a key social
determinant of health, i.e., income. Two recent Cochrane reviews [54,55] assessed the health effects of UCTs: the first in the
context of (humanitarian or natural) disasters and the second as a social protection intervention for reducing poverty and
vulnerabilities (e.g., orphanhood, old age, or HIV infection). Both reviews included studies conducted in low- and middle-
income countries only and had as primary outcomes the use of health services and health outcomes. Secondary outcomes
were relevant social determinants of health (e.g., assets, education, labor force participation, parenting quality, and extreme
poverty) and health care expenditure.
Examples of challenges
Challenges 2 and 3: Most studies included in the review of UCTs as a social protection intervention were conducted by
economists. Outcome reporting in the economic literature may not take into account considerations necessary for evidence
synthesis, such as choosing and defining outcomes in common with already existing studies on the same topic or reporting
intracluster correlation coefficients in cluster randomized trials. Some studies have dozens of very similar outcomes (e.g.,
number of goats, number of cows, number of chickens, etc.), making it difficult to choose which one to report in a systematic
review. Moreover, for many outcome measures used (in particular indices of food security and diet diversity), no agreed
minimal important difference exists. The Summary of Findings table went through several iterations during the review process
before agreement was reached on which and how many outcomes to report.
Challenges 4 and 5: In the review of UCTs for disaster relief, no high-quality evidence was identified. In addition, all included
studies investigated UCTs as a response to only one type of disaster, namely droughts, which are different from most disasters
in that droughts can be anticipated with a relatively long lead time before the consequences of the disaster materialize.
Accordingly, the evidence was seriously indirect as well as low quality. Nevertheless, the UN at the World Humanitarian
Summit in Istanbul 2016 called for making UCTs the default option for help during disasters. Intuitively, this seems plausible as
UCTs in a short-term disaster context are (compared to in-kind transfers) swift and fairly easily to administer. However, this
view does not account for potential crowding out effects of UCTs, i.e., unintended negative effects of UCT provision on other
types of financial assistance during disasters.
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We identified nine studies [12e16,28e31] that specif-
ically described the experiences of guideline development
agencies or systematic review groups in applying GRADE
to public health topics.
Rehfuess and Akl gathered insights from 25 stake-
holders in 12 organizations about their experiences and
views of using GRADE in the field of public health [14].
They grouped the challenges identified by participants into
six categories:
 Complexity of public health interventions.
 Choice of outcomes and outcome measures.
 Ability to discriminate between different types of
observational studies.
 Use of nonepidemiological evidence.
 GRADE terminology.
 GRADE and guideline development process.
Issues relating to GRADE terminology included defini-
tions of ‘‘quality of evidence,’’ the use of the term ‘‘obser-
vational study,’’ and different understandings of terms such
as ‘‘low-quality evidence’’ and ‘‘weak recommendations.’’
Participants reported challenges relating to the methodolog-
ical difficulties of systematically reviewing nonrandomized
studies, applying GRADE criteria to narrative synthesis inthe absence of a pooled effect estimate, difficulties with
the evidence-to-recommendations process, and concerns
about the resources required to implement GRADE meth-
odology [14].
Five reports [12,13,15,28,30] have described experi-
ences of using GRADE in the context of World Health Or-
ganization (WHO) guideline development. Akl et al
reported their experiences of applying GRADE in the
development of a WHO Department of HIV/AIDS guide-
line on public health interventions for men who have sex
with men and transgender people [12]. They describe the
solutions they developed within a single guideline for the
following nine challenges:
 Heterogenous and complex interventions.
 Paucity of trial data.
 Selecting outcomes of interest.
 Using indirect evidence.
 Integrating values and preferences.
 Considering resource use.
 Addressing social and legal barriers.
 Wording of recommendations.
 Developing global guidelines.
Dedios et al. evaluated the methodological quality and
implementability of guidelines produced by the WHO
Department of Nutrition for Health and Development
Case study 2 Cochrane systematic reviews to inform WHO malaria vector control guidelines
Contributed by: Leslie Choi
Background
In 2016, the WHO commissioned the development of new guidelines for malaria vector control [56] in partnership with the
Cochrane Infectious Diseases Group (CIDG) based at the Liverpool School of Tropical Medicine. CIDG contributed eight
systematic reviews [57e64] (five de novo, two updates, and one previously published review) that were used to inform the
recommendations made in these guidelines.
Examples of challenges
Challenges 2 and 3: Vector control tools are typically public health interventions distributed at a community level. To evaluate
efficacy at a community level, appropriate study designs with applicable outcomes are required. The main challenge
encountered with these guidelines is how to tailor the guidelines for the correct target audience. Are they for individuals
wanting to protect themselves from malaria or for national malaria program planners? Paradoxically, increased protection for
some individuals may translate into increased risk for others in the community who are not as well protected. Leading on from
this, it is difficult to assess whether the study evidence included in the systematic reviews demonstrates community protection.
For example, the systematic review on topical repellents combined studies that distributed the intervention at an individual
level and those that distributed at a community level. Therefore, it was unclear if the conclusions drawn from that review were
applicable to both contexts.
Challenge 4: Some modelling studies have suggested that poor coverage of vector control tools leads to more harm than good in
a community by protecting a few individuals at the expense of the majority. However, these findings were difficult to capture
and reconcile with the evidence from RCTs within the Summary of Findings and by extension the Evidence to Decision (EtD)
framework.
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evaluation may reflect limitations of GRADE guidance,
specifically citing NRS, time requirements, and wordingCase study 3 Czech national public health guideline on 1
Contributed by: Miloslav Klugar
Background
One-day surgery was identified as a public health topic within the
Committee (representatives of important policymakers in the Cz
Information and Statistics, Czech Health Research Council, and h
definitions in different health systems worldwide; the definition
‘‘surgical performance (diagnostic and therapeutic) for hospitaliz
including one overnight stay).’’ In the Czech Republic, there are
surgery regime, while in other hospitals patients may be routine
One-day surgery clearly involves surgeons as a key audience, b
policymakers. In addition, following GRADE guidance, it was clea
be engaged, as timely discharge from hospital and patient safet
Examples of challenges
Challenge 1: Initially the guideline panel membership included onl
identifying which surgical procedures should be covered by 1-da
professionals, patients, and other relevant stakeholders to join the
panel realized that social work/community care stakeholders sho
from health and social insurance organizations, as well as home
organizations/sectors and managing the work of such a diverse
Challenge 2: Although the Population, Intervention, Comparison, O
health questions, the panel faced a challenge in prioritizing clinic
terms of the identification and management of postsurgical comor strength of recommendations as issues. Alexander
et al. investigated why WHO guideline developers make
‘‘discordant recommendations,’’ i.e., strong-day surgery
national Clinical Practice Guidelines project by the Guarantor
ech Republic from the Ministry of Health, Institute of Health
ealth insurance organizations). One-day surgery has various
for the Czech health system agreed by guideline panellists is
ation not exceeding 1 day (up to 24 hours of hospitalization,
several surgical procedures in some hospitals in the 1-day
ly hospitalized for the same surgical procedures for 3-6 days.
ut also health care users, health care providers, and
r that social work and community care stakeholders needed to
y following discharge depend on social and community care.
y surgeons and methodologists and the focus was on
y surgery. There was initial resistance to inviting allied health
panel. Furthermore, after framing the guideline questions the
uld also be on the panel and that representation was needed
care organizations. Identifying representatives from different
guideline panel presented a challenge.
utcome format is straightforward in its application to public
al versus social and community care outcomes, particularly in
plications and patient safety after discharge from hospital.
Case study 4 European Breast Guidelines
Contributed by: Jesus Lopez Alcalde and Zuleika Saz Parkinson
Background
The European Commission’s Joint Research Center (JRC) supports European Union policies with independent scientific evidence
[65]. The JRC coordinates the development of the European guidelines for breast cancer screening and diagnosis [66] (in short,
the European Breast Guidelines). These guidelines follow GRADE [67]. The European Breast Guidelines provide
recommendations on population-based breast cancer screening programs and diagnostic procedures for breast cancer
[10,68,69]. The target audience of the guidelines is heterogeneous, covering health care providers, service users, and
policymakers.
Examples of challenges
Challenges 1 and 2: To define the perspective of the European Breast Guidelines was not straightforward. Some questions are
purely clinical, taking an individual perspective, while others have a population perspective. These aspects influence the
selection of the guideline questions and outcomes. The prioritization of the outcomes to determine the effects of breast cancer
screening programs is also challenging; some panellists may take the safety of screening interventions for granted and be
reluctant to include harms as outcomes.
Challenges 3 and 4: The GRADE approach requires a multidisciplinary team with specific skills, which may not be available in all
public health institutions. Therefore, certain tasks must be outsourced. The first guideline developed with GRADE in a public
health institution can be logistically complicated, but the replication in future guidelines is expected to be more straightforward.
Challenge 5: As RCTs for some questions are scarce, or even thought to be unethical, the use of GRADE is expected to generate
conditional recommendations. The misconception that GRADE gives too much weight to RCT evidence may partly explain this.
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dence. Their interviews with guideline panel members
identified several challenges or barriers to GRADE applica-
tion, including insufficient guidance on prioritizing out-
comes and rating NRS, different professional
backgrounds among panel members, and a political envi-
ronment that favors strong recommendations [13]. In a
further study by Alexander et al, interviews with GRADE
methodologists also identified the political environment as
a driver of ‘‘discordant’’ recommendations as well as issues
with the management of conflicts of interest, urgent time-
scales, and the feasibility of implementing recommenda-
tions [28]. Most recently, Gopinathan and Hoffman
interviewed 35 senior WHO staff on their views about
changes in WHO guideline development because its pro-
cesses were reformed starting in 2007 [30]. Among several
themes identified in the interviews, challenges were identi-
fied relating to the assessment of NRS and qualitative
studies, concerns which the authors note were subsequently
addressed with the introduction of ROBINS-I [32] and
GRADE-CERQual [33].
Two reports [16,31] relate to guidelines or projects at the
European Center for Disease Prevention and Control
(ECDC). Within a review of evidence-based guideline
methodology, the authors described issues with GRADE’s
terminology and treatment of NRS and noted an absence
of guidance relating to economic and epidemiological
models, studies of incidence and prevalence of disease,
and microbiological studies. They further noted the need
to integrate other aspects of decision-making with GRADE
processes, such as prioritization of topics and selection ofexperts [16]. The ECDC Project on a Framework for Rating
Evidence in Public Health subsequently reported the dis-
cussions and conclusions of an international expert meeting
on evaluating and grading evidence on infectious disease
prevention and control [31]. This report concluded that
GRADE can be applied successfully to guideline questions
concerning the incidence and prevalence of diseases and
suggested that some types of nonrandomized evidence,
such as a body of evidence from interrupted time series
(ITS) designs, should be rated more highly in GRADE as-
sessments. This is an area for which the GRADE Working
Group has sought examples and operationalization since its
inception but failed to receive or identify clear methodolog-
ical suggestions that would allow rating ITS higher.
Finally, Burford et al. (2012) summarized the benefits
and challenges when applying GRADE to Cochrane public
health systematic reviews [29]. These challenges related to
NRS and rating certainty of evidence, as well as what to do
in the absence of a pooled effect size. The article addressed
some misconceptions relating to initial ratings of random-
ized and observational studies and noted that concerns
about low certainty of evidence are not unique to public
health. The authors further noted that GRADE is particu-
larly helpful in addressing certain issues commonly
encountered when synthesizing public health evidence,
including the importance of context and the heterogeneity
that arises when combining findings from different public
health programs and health systems.
The studies identified in the scoping review range in
publication date from 2011 to 2018. During this period, de-
velopments in GRADE methodology occurred that
Table 1. Key challenges, examples, and proposed solutions in applying GRADE guidance to public health topics
Challenge Examples Solutions
1. Incorporating diverse perspectives Convening guideline panels with diverse
perspectives from different sectors,
e.g., Czech national public health
guideline on 1-day surgery (Box 3)
Combining individual and population
perspectives, e.g., malaria vector
control reviews (Box 2) and European
Breast Guidelines (Box 4)
Forthcoming GRADE Public Health
article,
Addressing social determinants in public
health systematic reviews and
guidelines using GRADE
Adapt GRADE training materials for
nonhealth and policy audiences
2. Selecting and prioritizing outcomes Addressing individual and population
outcomes in the same guideline or
review, particularly when benefits and
harms differ depending on the
perspective taken, e.g., Cochrane
reviews and WHO guideline on malaria
vector control (Box 2)
Achieving consensus on critical outcomes
across different sectors, e.g., health
care, social work, community care, and
insurers in Czech national public health
guideline on 1-day surgery (Box 3)
Health vs. nonhealth outcomes, e.g., in
transport policy
3. Interpreting outcomes and identifying
a threshold for decision-making
Outcomes that have no defined
thresholds, e.g., Cochrane reviews of
unconditional cash transfers (Box 1)
Small changes may have important health
impacts at population level but not at
individual level, e.g., taxation to
address health externalities
Different thresholds will have
implications for modelling of the
population health effects of policies
and public health interventions
Forthcoming GRADE Public Health
article,
Considerations when applying GRADE to
population-level outcomes in public
health systematic reviews and
guidelines
4. Assessing certainty of evidence from
diverse sources, including
nonrandomized studies
Cochrane reviews of environmental
interventions to reduce sugar-
sweetened beverage consumption and
interventions to reduce ambient air
pollution found large differences in
internal validity both within and across
NRS
Natural experiments may involve
randomization or allocation that is ‘‘as
good as’’ random, and may be the best
possible evidence for a policy-related
question but are treated as
nonrandomized or observational studies
and generally start with a rating of low-
quality evidence
Contribute worked examples from public
health reviews and guidelines to other
GRADE project groups, especially the
GRADE NRS group
Operationalize criteria for when
interrupted time series may avoid
typical selection and confounding bias
and be rated as moderate certainty
5. Addressing implications for decision
makers, including concerns about
conditional recommendations
Making strong recommendations despite
very low certainty evidence, e.g.,
unconditional cash transfers for
disaster relief (Box 1)
Collaboration with GRADE EtD group
ongoing since May 2019
48 M. Hilton Boon et al. / Journal of Clinical Epidemiology 135 (2021) 42e53addressed many, if not most, of the challenges identified.
For example, GRADE changed its terminology about the
quality of evidence to be more flexible. Furthermore,
GRADE had already altered the traditional evidence hierar-
chy by allowing a body of evidence from observationalstudies to be rated as high-quality evidence. In addition, ar-
ticles have since addressed the use of GRADE in the
absence of meta-analyses [18,34]. Overall, the existing
literature is consistent in identifying certain challenges in
using GRADE within public health systematic reviews
Fig. 1. Process of developing the scope and priorities of the GRADE Public Health Group.
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perspectives within political environments, rating the cer-
tainty of nonrandomized evidence and wording or strength
of recommendations. Most of the included studies make
suggestions or recommendations to address these issues,
and many solutions have been developed. However, addi-
tional solutions require further investigation, development,
and testing to ensure a systematic approach that is coherent
with existing GRADE guidance while also meeting the
needs of stakeholders.4. Analysis: key challenges and solutions when
applying GRADE guidance to public health topics
To formulate an approach to addressing the issues iden-
tified through the scoping review, the GRADE Public
Health Group organized the challenges into themes, map-
ped these to current GRADE Working Group activities,
identified gaps, discussed and presented potential activities
and outputs, and reached consensus on a program of work
including publications, contributions to other project
groups, and training. The project group also identified
and discussed case studies through which the relevance
and applicability of the five themes were explored and
confirmed in a variety of public health contexts, including
both systematic reviews and guidelines. Figure 1 summa-
rizes the process of developing the scope and priorities of
the GRADE Public Health Group, leading to a focus on five
key challenges.
The five key challenges are described narratively below.
Table 1 summarizes the analysis of the challenges, gaps,
and the project group response, including existing solu-
tions, planned outputs, and other activities. Boxes 1-4 pre-
sent the case studies, which have been selected to represent
a diversity of public health topics (social determinants of
health, infectious diseases, organization of health care,
and screening) drawn from both systematic reviews and
guidelines (ten Cochrane reviews, one national public
health guideline, and one pan-national guideline develop-
ment program).
4.1. Challenge 1: incorporating diverse perspectives
Many health guidelines are intended for multidisci-
plinary audiences, including different health professions,health care managers, health policymakers, patients, and
carers. The Health in All Policies approach is arguably
where this becomes most challenging, for example, when
considering the health impacts of migration policy [35].
In addition, to address the wider determinants of health,
public health guidelines may be targeted at professionals,
policymakers, and other stakeholders from nonhealth disci-
plines and sectors whose perspectives on health evidence
may vary; indeed, sometimes the primary responsibility
for financing and/or implementing public health interven-
tions lies within these sectors. For example, the National
Institute for Health and Care Excellence guideline on phys-
ical activity and the environment is aimed at local govern-
ment and their contractors, employers, and community
organizations responsible for public spaces, housing author-
ities, public transport planners and providers, and organiza-
tions that support people with limited mobility [36]. The
way that such varied audiences frame policy questions,
the extent to which these audiences value health protection
and improvement, and the priorities placed on various pol-
icy approaches may all differ substantially [37], but need to
be understood if the guideline is to achieve its aims.
Furthermore, different professions and stakeholder groups
may represent different ‘‘cultures of evidence’’ in which
legislation, regulations, and other contextual factors may
take priority over scientific research [38].
4.2. Challenge 2: selecting and prioritizing outcomes
Differences in perspectives and in cultures of evidence
also translate into challenges in selecting relevant outcomes
and agreeing which outcomes are critical to decision-
making. For example, in transportation policy any recom-
mendations about traffic management would ideally
consider all relevant outcomes, including respiratory health,
changes in physical activity levels, emergency admissions,
and safety for vulnerable road users. However, transport
policymakers might not view these outcomes as critical
when weighed against traffic flow, commuting times, road
traffic collisions, costs, provision of goods, or public
opinion. Relatedly, challenges may arise when benefits
are realized to a greater extent by communities than by in-
dividuals who receive treatment (e.g., immunizations which
lead to herd immunity) [26]. A further challenge relates to
the potential trade-off between population health and health
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achieved at the expense of widening inequalities. For
example, a public health intervention such as screening or
wellness checks may succeed in improving a population’s
overall morbidity and mortality, but if the improved out-
comes are predominantly achieved in a subgroup of higher
socioeconomic status (SES), health inequality may inadver-
tently be increased by widening the difference between the
outcomes of high versus low SES subgroups. The GRADE
equity guidelines [21,24,26,27] are helpful in addressing
this challenge. Finally, advancing health in the context of
the Sustainable Development Goals implies that health ben-
efits may need to be weighed against broader environ-
mental, economic, and social impacts and their potential
interactions [39e41].4.3. Challenge 3: interpreting outcomes and identifying
a threshold for decision-making
The interpretation of evidence for a given outcome
needs to be informed by knowledge of what change in that
outcome would make a meaningful difference in a given
context. A change in a health outcome that might be
deemed too small to be of importance to a patient may
be perceived differently from a whole population perspec-
tive, where small effects in many individuals may be
magnified to differences that are important for public health
interventions and policy [42], as can be seen, for example,
in population-wide salt reduction programs [43]. Further-
more, many interventions at the population level are imple-
mented for primarily nonhealth reasons but act on key
determinants of health, for example, transport infrastruc-
ture, housing, and general taxation, and therefore may have
profound health and health equity impacts. In these circum-
stances, the effect size of an intervention may not be as
informative for decision-making as the expected direction
of overall health impact (e.g., likely results in health gains
or health harms). Relatedly, equipoise may not exist for the
primary nonhealth outcome [44]. These considerations of
population-level impact, social determinants of health and
inequalities, and lack of equipoise may all influence views
on what constitutes an important difference and the
required degree of precision to support decision-making.4.4. Challenge 4: assessing certainty of evidence from
diverse sources, including NRS
In public health, where randomized studies are less com-
mon and often infeasible in comparison with other areas of
health, some types of NRS may provide greater certainty
than others when investigating the health effects of policy
or social interventions. For example, natural experiment
studies may address selection bias and confounding
through designs such as ITS or regression discontinuity,
which may support stronger causal inference than other
observational designs such as cohort and case-controlstudies [45]. Two recent Cochrane reviews, one on environ-
mental interventions to reduce sugar-sweetened beverage
consumption [46] and one on interventions to reduce
ambient air pollution [47] used nonrandomized intervention
studies where no randomized studies were available; how-
ever, there were large differences in internal validity both
within and across NRS. Existing GRADE guidance has
noted that the potential exists for different NRS designs
to provide moderate-quality evidence but that examples
are yet to be identified [25]. An active research agenda ex-
ists in the area of NRS and evidence synthesis, including
the activity of the GRADE NRS group, the development
of ROBINS-I within the Cochrane Risk of Bias Methods
Group, and further adaptations of ROBINS-I for different
NRS designs [32,48]. Addressing this challenge by identi-
fying relevant examples from public health policy and
applying these new tools therefore seems a promising cata-
lyst through which solutions to other challenges may also
emerge.4.5. Challenge 5: addressing implications for decision
makers, including concerns about conditional
recommendations
As demonstrated in the scoping review, the predomi-
nance of ‘‘weak’’ recommendations in public health guide-
lines has been of concern to guideline developers and
policymakers. GRADE has addressed this issue by chang-
ing the terminology (weak recommendations are in public
health primarily labeled conditional and the conditions
should be specified). It is already recognized that public
health produces several situations in which action may be
strongly recommended despite low or very low certainty,
including:
 Life-threatening situations.
 Uncertain benefit but certain harm.
 Potential equivalence of effectiveness in which one
option is clearly more or less risky or costly.
 Potential for catastrophic harm [49].
Early strong recommendations in the context of very low
certainty evidence emphasized that GRADE had recog-
nized this problem [50]. However, examples may still be
encountered, such as in fiscal policy, where economists
might strongly recommend austerity policies while public
health might produce a weak recommendation in terms of
health outcomes. Grading recommendations as ‘‘condi-
tional’’ rather than ‘‘weak’’ may partially address this issue,
but guideline developers may also need to better contextu-
alize and ground such recommendations in ‘‘what else we
might know.’’ A Bayesian decision theory approach has
been proposed in the context of this problem [51e53]
and could be further explored. A key challenge for GRADE
in public health is therefore to identify how to reconcile the
tension between the methodologically correct presentation
of evidence and recommendations as per GRADE and the
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from the perspective of decision makers in political
environments.
[Boxes 1-4: Case studies: four examples of challenges of
applying GRADE in public health systematic reviews and
guidelines].
5. Discussion and conclusion
The views sourced from a participatory workshop, a
scoping review, and four case studies suggest that key pub-
lic health-related challenges in application of GRADE
methodology include the incorporation of stakeholder per-
spectives from outside the health sector; agreement on the
interpretation and prioritization of diverse outcomes; defini-
tion and interpretation of thresholds for population health
and nonhealth outcomes; assessing the certainty of evi-
dence from diverse sources and NRS designs; and address-
ing implications for decision makers, including the
presentation of strength of recommendations to ensure util-
ity and acceptability for stakeholders.
These challenges may be categorized into three different
types, as per the different types of solutions that may be
proposed. The first type of solution is to identify the
training needs of public health guideline developers (and
their stakeholders) in understanding and using the GRADE
concept, i.e., as per existing guidance. As different disci-
plines or ‘‘cultures of evidence’’ come together in public
health, it will take time to speak a common (GRADE) lan-
guage. The second type of solution has to do with applying
existing GRADE guidance, including current develop-
ments, to the public health context. As identified within
the scoping review, most of the existing GRADE guidance,
both on rating certainty of the evidence and moving from
evidence to decision, is already applicable to the public
health context but would benefit from translation and exam-
ples, so that its relevance to public health practice and pol-
icy can be more readily recognized and a population
perspective can be consistently reflected in all steps. The
third type of solution is to advance the GRADE methodol-
ogy where existing guidance falls short, i.e., to develop new
GRADE guidance where necessary and appropriate.
The GRADE Public Health Group has considered the
challenges in the context of other GRADE outputs and
project groups, as well as other ongoing research in guide-
line methodology [41,70], with the aim of avoiding unnec-
essary duplication of effort. The solutions proposed by the
group include the following package of work:
 Further GRADE concept articles or guidance to
address social determinants in public health system-
atic reviews and guidelines using GRADE, consider-
ations when applying GRADE to population-level
outcomes and criteria to assess certainty of interrup-
ted time series.
 The ongoing development and dissemination of
detailed examples of the application of GRADE topublic health topics in coordination with other
GRADE project groups, including the NRS and EtD
groups.
 Adaptation of GRADE training materials for public
health and public policy audiences.
By providing a single, carefully documented, rigorous,
and transparent method of evaluating evidence, GRADE
serves to increase the trustworthiness, implementation,
and adaptability of systematic reviews and guidelines,
while also helping to reduce research waste. It is therefore
our aim to address and mitigate any barriers to using
GRADE in public health and, through the work of the
GRADE Public Health group, to build bridges and increase
mutual understanding across the wide range of policy and
research areas that intersect in the population health
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